PE Anti-UQCRC2 抗体 [EPR13051]
PE Anti-UQCRC2 antibody [EPR13051]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal UQCRC2 antibody - conjugated to PE.
別名を表示する
Complex III subunit 2, Core protein II, Ubiquinol-cytochrome-c reductase complex core protein 2, UQCRC2
関連する標識済み抗体及び組成の異なる製品 (10)
-
Anti-UQCRC2 antibody [EPR13051]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-UQCRC2 antibody [EPR13051]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-UQCRC2 antibody [EPR13051]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-UQCRC2 antibody [EPR13051]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-UQCRC2 antibody [EPR13051]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-UQCRC2 antibody [EPR13051]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-UQCRC2 antibody [EPR13051]
-
Anti-UQCRC2 antibody [EPR13051] - BSA and Azide free
-
660 APC
APC Anti-UQCRC2 antibody [EPR13051]
-
HRP Anti-UQCRC2 antibody [EPR13051]
下記製品にもご興味をお持ちいただけるかもしれません:
こちらの製品も推奨する理由
この製品は、同様の実験や関連する研究で広く使用されていることから推奨させていただいております。
お客様の実験に適するかご確認いただくため、必ず製品データシートをご確認いただくことをお勧めいたします。ご不明点等ございましたら、テクニカルサポートチームまでお問い合わせください。
製品の詳細
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UQCRC2 participates in producing ATP which is the primary energy currency in cells. It forms part of the mitochondrial complex III a multi-subunit enzyme complex essential for efficient electron transfer and proton pumping. UQCRC2 contributes to establishing the proton gradient across the mitochondrial membrane which drives ATP synthesis through chemiosmotic processes. This function is critical for maintaining cellular energy homeostasis.
Pathways
The functionality of UQCRC2 links significantly to the oxidative phosphorylation and respiratory chain pathways. It ensures proper function in the oxidative phosphorylation pathway which generates the majority of ATP in aerobic organisms. UQCRC2 is associated with proteins such as cytochrome b and cytochrome c1 which collaborate in the electron transport chain ensuring the efficiency of the process and integrity of energy conversion.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
関連製品
Alternative Version
Primary Antibodies
AB240368
Anti-UQCRC2 antibody [EPR13051] - BSA and Azide free
primary-antibodies
uqcrc2-antibody-epr13051-bsa-and-azide-free-ab240368
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com